Updates are available Correction dated 2025-01-18
Click to view Correction: https://doi.org/10.1186/s12933-024-02562-y
-
Authors
Seppälä, Matias
Lukander, Heidi
Wadén, Johan
Eriksson, Marika I.
Harjutsalo, Valma
Groop, Per-Henrik
Thorn, Lena M.
,
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 8 April 2024
Accepted: 22 October 2024
First Online: 29 October 2024
Change Date: 9 January 2025
Change Type: Update
Change Details: The original online version of this article was revised: The Graphical Abstract has been included in the article.
Change Date: 18 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12933-024-02562-y
Declarations
:
: The study was approved by the Ethics Committee of Helsinki University Hospital, and it was performed in accordance with the Declaration of Helsinki. Each participant provided written informed consent.
: Not applicable.
: M.I.E is a shareholder of BCB Medical. P-H.G. reports receiving lecture fees from Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elo Water, Genzyme, Medscape, Merck, Sharp&Dohme, Mundipharma, Novartis, Novo Nordisk, PeerVoice, Sanofi, and Sciarc. P-H. G reports being an advisory board member for AbbVie, Astellas Pharma, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Janssen Pharmaceuticals, Medscape, Merck, Sharp & Dohme, Mundipharma, Nestlé, Novartis, Novo Nordisk, and Sanofi. No other potential conflicts of interest relevant to this article were reported.
